HEADER IMMUNE SYSTEM 18-FEB-18 6FS1 TITLE MCL1 IN COMPLEX WITH AN INDOLE ACID LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN COMPND 6 EAT/MCL1,MCL1/EAT; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MCL1, INDOLE ACID, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.KASMIRSKI,D.HARGREAVES REVDAT 1 26-DEC-18 6FS1 0 JRNL AUTH A.E.TRON,M.A.BELMONTE,A.ADAM,B.M.AQUILA,L.H.BOISE, JRNL AUTH 2 E.CHIARPARIN,J.CIDADO,K.J.EMBREY,E.GANGL,F.D.GIBBONS, JRNL AUTH 3 G.P.GREGORY,D.HARGREAVES,J.A.HENDRICKS,J.W.JOHANNES, JRNL AUTH 4 R.W.JOHNSTONE,S.L.KAZMIRSKI,J.G.KETTLE,M.L.LAMB,S.M.MATULIS, JRNL AUTH 5 A.K.NOOKA,M.J.PACKER,B.PENG,P.B.RAWLINS,D.W.ROBBINS, JRNL AUTH 6 A.G.SCHULLER,N.SU,W.YANG,Q.YE,X.ZHENG,J.P.SECRIST,E.A.CLARK, JRNL AUTH 7 D.M.WILSON,S.E.FAWELL,A.W.HIRD JRNL TITL DISCOVERY OF MCL-1-SPECIFIC INHIBITOR AZD5991 AND JRNL TITL 2 PRECLINICAL ACTIVITY IN MULTIPLE MYELOMA AND ACUTE MYELOID JRNL TITL 3 LEUKEMIA. JRNL REF NAT COMMUN V. 9 5341 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 30559424 JRNL DOI 10.1038/S41467-018-07551-W REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 PACIOREK REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 80.2 REMARK 3 NUMBER OF REFLECTIONS : 34077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1726 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.15 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 447 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2465 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 426 REMARK 3 BIN R VALUE (WORKING SET) : 0.2440 REMARK 3 BIN FREE R VALUE : 0.2946 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 21 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2404 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 383 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02600 REMARK 3 B22 (A**2) : -2.05550 REMARK 3 B33 (A**2) : 2.02940 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.62780 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.203 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.130 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.122 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.114 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2570 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3471 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 939 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 62 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 468 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2570 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 317 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3462 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.86 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.52 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.20 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 9.7469 -6.5209 18.2445 REMARK 3 T TENSOR REMARK 3 T11: -0.0480 T22: -0.0945 REMARK 3 T33: -0.0952 T12: -0.0053 REMARK 3 T13: -0.0179 T23: -0.0012 REMARK 3 L TENSOR REMARK 3 L11: 0.7617 L22: 0.8486 REMARK 3 L33: 1.1533 L12: -0.0043 REMARK 3 L13: -0.2215 L23: -0.3065 REMARK 3 S TENSOR REMARK 3 S11: -0.0030 S12: -0.0129 S13: -0.0568 REMARK 3 S21: -0.0014 S22: 0.0236 S23: -0.0341 REMARK 3 S31: 0.1330 S32: -0.0456 S33: -0.0206 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 6.2543 21.1020 11.7369 REMARK 3 T TENSOR REMARK 3 T11: -0.0908 T22: -0.1022 REMARK 3 T33: -0.1125 T12: 0.0067 REMARK 3 T13: -0.0042 T23: -0.0033 REMARK 3 L TENSOR REMARK 3 L11: 1.0653 L22: 1.0516 REMARK 3 L33: 1.0522 L12: -0.1408 REMARK 3 L13: -0.0771 L23: -0.1384 REMARK 3 S TENSOR REMARK 3 S11: 0.0102 S12: -0.0304 S13: 0.0489 REMARK 3 S21: 0.0105 S22: -0.0024 S23: -0.0468 REMARK 3 S31: -0.0834 S32: -0.0286 S33: -0.0078 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FS1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200008846. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JAN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34104 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 64.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 79.8 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 18.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG MME 5K, 2% PEG 400, 0.1M MES REMARK 280 PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.25950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 320 53.70 34.72 REMARK 500 HIS B 320 53.89 36.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 688 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH B 692 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH B 693 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH B 694 DISTANCE = 6.49 ANGSTROMS REMARK 525 HOH B 695 DISTANCE = 9.33 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4Q A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4Q B 403 DBREF 6FS1 A 174 321 UNP Q07820 MCL1_HUMAN 174 321 DBREF 6FS1 B 174 321 UNP Q07820 MCL1_HUMAN 174 321 SEQADV 6FS1 ASP A 172 UNP Q07820 EXPRESSION TAG SEQADV 6FS1 ASP A 173 UNP Q07820 EXPRESSION TAG SEQADV 6FS1 SER A 193 UNP Q07820 ALA 193 CONFLICT SEQADV 6FS1 SER A 196 UNP Q07820 THR 196 CONFLICT SEQADV 6FS1 LEU A 199 UNP Q07820 MET 199 CONFLICT SEQADV 6FS1 GLU A 201 UNP Q07820 ARG 201 CONFLICT SEQADV 6FS1 ALA A 202 UNP Q07820 SER 202 CONFLICT SEQADV 6FS1 ALA A 205 UNP Q07820 THR 205 CONFLICT SEQADV 6FS1 GLY A 206 UNP Q07820 SER 206 CONFLICT SEQADV 6FS1 ARG A 208 UNP Q07820 LYS 208 CONFLICT SEQADV 6FS1 ASP B 172 UNP Q07820 EXPRESSION TAG SEQADV 6FS1 ASP B 173 UNP Q07820 EXPRESSION TAG SEQADV 6FS1 SER B 193 UNP Q07820 ALA 193 CONFLICT SEQADV 6FS1 SER B 196 UNP Q07820 THR 196 CONFLICT SEQADV 6FS1 LEU B 199 UNP Q07820 MET 199 CONFLICT SEQADV 6FS1 GLU B 201 UNP Q07820 ARG 201 CONFLICT SEQADV 6FS1 ALA B 202 UNP Q07820 SER 202 CONFLICT SEQADV 6FS1 ALA B 205 UNP Q07820 THR 205 CONFLICT SEQADV 6FS1 GLY B 206 UNP Q07820 SER 206 CONFLICT SEQADV 6FS1 ARG B 208 UNP Q07820 LYS 208 CONFLICT SEQRES 1 A 150 ASP ASP LEU TYR ARG GLN SER LEU GLU ILE ILE SER ARG SEQRES 2 A 150 TYR LEU ARG GLU GLN ALA THR GLY SER LYS ASP SER LYS SEQRES 3 A 150 PRO LEU GLY GLU ALA GLY ALA ALA GLY ARG ARG ALA LEU SEQRES 4 A 150 GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN ARG ASN SEQRES 5 A 150 HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS LEU ASP SEQRES 6 A 150 ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER ARG VAL SEQRES 7 A 150 MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN TRP GLY SEQRES 8 A 150 ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE VAL ALA SEQRES 9 A 150 LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS ILE GLU SEQRES 10 A 150 PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL ARG THR SEQRES 11 A 150 LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP ASP GLY SEQRES 12 A 150 PHE VAL GLU PHE PHE HIS VAL SEQRES 1 B 150 ASP ASP LEU TYR ARG GLN SER LEU GLU ILE ILE SER ARG SEQRES 2 B 150 TYR LEU ARG GLU GLN ALA THR GLY SER LYS ASP SER LYS SEQRES 3 B 150 PRO LEU GLY GLU ALA GLY ALA ALA GLY ARG ARG ALA LEU SEQRES 4 B 150 GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN ARG ASN SEQRES 5 B 150 HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS LEU ASP SEQRES 6 B 150 ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER ARG VAL SEQRES 7 B 150 MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN TRP GLY SEQRES 8 B 150 ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE VAL ALA SEQRES 9 B 150 LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS ILE GLU SEQRES 10 B 150 PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL ARG THR SEQRES 11 B 150 LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP ASP GLY SEQRES 12 B 150 PHE VAL GLU PHE PHE HIS VAL HET E4Q A 401 43 HET EDO B 401 4 HET EDO B 402 4 HET E4Q B 403 43 HETNAM E4Q 7-[3-[(1,5-DIMETHYLPYRAZOL-3-YL)METHYLSULFANYLMETHYL]- HETNAM 2 E4Q 1,5-DIMETHYL-PYRAZOL-4-YL]-3-(3-NAPHTHALEN-1- HETNAM 3 E4Q YLOXYPROPYL)-1~{H}-INDOLE-2-CARBOXYLIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 E4Q 2(C34 H35 N5 O3 S) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *383(H2 O) HELIX 1 AA1 ASP A 172 GLY A 192 1 21 HELIX 2 AA2 ALA A 202 HIS A 224 1 23 HELIX 3 AA3 HIS A 224 ASP A 236 1 13 HELIX 4 AA4 ASN A 239 SER A 255 1 17 HELIX 5 AA5 ASN A 260 ILE A 281 1 22 HELIX 6 AA6 GLN A 283 SER A 285 5 3 HELIX 7 AA7 CYS A 286 GLN A 309 1 24 HELIX 8 AA8 ARG A 310 HIS A 320 1 11 HELIX 9 AA9 ASP B 173 GLY B 192 1 20 HELIX 10 AB1 ALA B 202 HIS B 224 1 23 HELIX 11 AB2 HIS B 224 ASP B 236 1 13 HELIX 12 AB3 ASN B 239 SER B 255 1 17 HELIX 13 AB4 ASN B 260 ILE B 281 1 22 HELIX 14 AB5 GLN B 283 SER B 285 5 3 HELIX 15 AB6 CYS B 286 GLN B 309 1 24 HELIX 16 AB7 ARG B 310 HIS B 320 1 11 SITE 1 AC1 12 MET A 231 VAL A 249 MET A 250 VAL A 253 SITE 2 AC1 12 ARG A 263 THR A 266 LEU A 267 PHE A 270 SITE 3 AC1 12 GLY A 271 HOH A 555 HOH A 572 HOH A 589 SITE 1 AC2 9 ARG A 300 THR A 301 ARG A 303 ASP A 304 SITE 2 AC2 9 ARG B 300 THR B 301 ARG B 303 ASP B 304 SITE 3 AC2 9 HOH B 588 SITE 1 AC3 4 ALA B 204 ALA B 205 ARG B 208 ASP B 313 SITE 1 AC4 12 MET B 231 VAL B 249 MET B 250 VAL B 253 SITE 2 AC4 12 ARG B 263 THR B 266 LEU B 267 PHE B 270 SITE 3 AC4 12 GLY B 271 HOH B 547 HOH B 580 HOH B 593 CRYST1 42.680 64.519 59.975 90.00 98.82 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023430 0.000000 0.003636 0.00000 SCALE2 0.000000 0.015499 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016873 0.00000